This page regroups important resources on antimicrobial resistance, material for UICC's members and partners, infographics, videos and other important documents and links.
The threat of antimicrobial resistance to cancer treatment and survival is a priority for UICC. Currently, knowledge and awareness of the impact of antimicrobial resistance on cancer outcomes within the cancer community is low. It is urgent that oncology professionals, cancer advocates, programme managers, patient groups and other stakeholders working in the field of cancer understand and address the factors that contribute to the development and spread of AMR and strategies for infection control.
In this regard, UICC will develop information to increase awareness and support the cancer community to come together and drive policy change, taking forward the WHO global action plan on antimicrobial resistance.
To sustain focus on the issue and mobilize action on addressing AMR, a special supplement of AMR Control emphasizing the impact of AMR on cancer care outcomes and was launched at the World Cancer Congress 2022. Written by over 50 experts committed to researching the scale of AMR and to finding workable solutions, the supplement is an excellent reference for the cancer community as well as being a key resource for advocacy efforts.
Image source: PHARMAC, NZ - https://www.pharmac.govt.nz/keepantibioticsworking/
Useful links for further reading
Antimicrobial resistance (AMR) or drug resistance, including antibiotic resistance, is a growing public health issue and needs urgent attention in countries around the world. Due to a variety of factors, people with cancer are particularly vulnerable to AMR, which is threatening the progress being made in cancer care.
The threat of antimicrobial resistance (AMR) and its impact on cancer treatment is a priority for UICC.
Share this page